to characterize the pathophysiologic mechanisms responsible for BBB disruption in chronic hypothyroidism. Footnotes aRossmeisl JH, Panciera DL. Blood-brain barrier disruption in canine chronic experimental J Vet Int Med 2009; 23: 698. hypothyroidism (abstract #45). bAnimal Health Diagnostic Laboratory, Michigan State University, East Lansing, MI cMicrosoft Excel, Random Number Generation, Microsoft Corp., Seattle, WA d 131Iodine, Cardinal Health, Charlottesville, VA e Thyrogen, Genzyme Corp., Framingham, Olympus AU400®, Olympus America, Inc., , NY f Cell-Dyne 3700, Abbott Laboratories, Abbott Park, Illinois g hHydrasys 2, Sebia Inc., Norcross, GA iHydragel HR Acid Violet, Sebia Inc., Norcross, GA jQuantikine DVE00, R & D Systems, Minneapolis, MN kSpectramax 250, Molecular Devices, Sunnyvale, CA lElecsys 2010, Roche Diagnostics, Mannheim, Germany mSAS version 9.1.3, Cary NC
to characterize the pathophysiologic mechanisms responsible for BBB disruption in chronic hypothyroidism. Footnotes aRossmeisl JH, Panciera DL. Blood-brain barrier disruption in canine chronic experimental hypothyroidism (abstract #45). J Vet Int Med 2009; 23: 698. bAnimal Health Diagnostic Laboratory, Michigan State University, East Lansing, MI cMicrosoft Excel, Random Number Generation, Microsoft Corp., Seattle, WA d 131Iodine, Cardinal Health, Charlottesville, VA e Thyrogen, Genzyme Corp., Framingham, f Olympus AU400®, Olympus America, Inc., , NY g Cell-Dyne 3700, Abbott Laboratories, Abbott Park, Illinois hHydrasys 2, Sebia Inc., Norcross, GA iHydragel HR Acid Violet, Sebia Inc., Norcross, GA jQuantikine DVE00, R & D Systems, Minneapolis, MN kSpectramax 250, Molecular Devices, Sunnyvale, CA lElecsys 2010, Roche Diagnostics, Mannheim, Germany mSAS version 9.1.3, Cary NC